Pandemrix Articles
EMA updates Rxing advice for GlaxoSmithKline’s Pandemrix reflecting possible narcolepsy link
18 April 2011
WHO says narcolepsy link with GSK’s flu vaccine Pandemrix needs further investigation
10 February 2011
GlaxoSmithKline sells Croatian research center to Galapagos, names new CFO and enters supply deal with Lonza; EMEA update on Avandia and Pandemrix
9 September 2010
European Medicines Agency to review GlaxoSmithKline’s flu vaccine Pandemrix for possible link with narcolepsy
31 August 2010
Europe’s CHMP updates on pandemic vaccines, backs use extensions for Reyataz and RoActemra, concludes Seroquel XR arbitration
26 April 2010
Showing 1-9 of 9 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
